Status
Conditions
Treatments
About
The present study will investigate the oral release and systemic pharmacokinetics of a panel water- and fat-soluble vitamins from two commercially-produced chewing gum formulations. Vitaball, Inc. (Ft. Thomas, KY) markets a line of vitamin-fortified gums. These products include Vitamingum Sport and Vitamingum Fresh, which are marketed to different consumer populations. There is currently no available data on the release of vitamins from these products in the oral cavity or the impact of chewing these products on plasma levels of the component vitamins following acute administration. The investigators hypothesize that these chewing gum products will increase both salivary and plasma levels of the component vitamins. The present study has two major objectives:
The test articles are commercially-marketed products and are currently available to participants outside the study (http://chewvitamingum.com). The present study is not intended to develop a treatment for a particular disease, but rather to determine if the vitamin components of these commercially-produced chewing gum products are bioaccessible or bioavailable. Vitamin supplements administered as tablets, capsules, caplets, or gummies might be regarded as the "standard of care".
Full description
Study Design The study will involve two phases. The first phase will be to compare the release of the component vitamins in two chewing gum products into the saliva. This will employ a parallel design in which half the subjects (7 - 8) chew a product marketed for athletes "Sport" and half (7 - 8) chew one marketed for immune system support "Immunity". The second phase will be to compare the acute effects of chewing the two gums on plasma levels of the component vitamins. A single-blinded, double cross-over design with 15 healthy human subjects will be employed. Subjects be randomly assigned to "Sport", "Immunity", or a placebo gum matched for color and flavor but without vitamins. Each phase will be separated by a one-week washout period.
Study Procedures 1. Screening: There will be a phone screening prior to medical screening at the University Park Clinical Research Center (CRC). This will be used to establish explain the study to the prospective participant, establish eligibility and set up an appointment for the medical screen.
2 Medical Screen: Prior to acceptance into the research study, participants must complete consent forms, a medical history form, and have measurements taken (height, weight, blood pressure). If female, a urine pregnancy test will be self-administered to ensure that the subject is not pregnant. If the subject is still eligible after these tests, a small amount of blood (10 mL) will be collected by a CRC nurse using a single needle stick. The blood will be screened for markers of liver function (alanine aminotransferase, aspartate aminotransferase, or bilirubin), kidney function (blood urea nitrogen), and iron status. If a blood sample cannot be collected, the nurse try a second time, or to withdraw from the study. If a second try is unsuccessful, the participant will be excluded from the study.
3 Research Study Overview: If eligible, the subjects will have four study days (1 visit to the Food Science Building and 3 visits to the CRC). The visit to the Food Science Building will be for collection of saliva samples and will last less than 1 h. The three visits to the CRC will be to collect blood samples and will be scheduled from 7:30 am to 6:00 pm. During this day, the subject will be required to remain at the GCRC from 7:30 am to 12:30 pm. The subject will be able to leave after 6:00 pm, but will need to return at 7:30 pm for an additional blood draw.
4 Prior to Study Visits: Subjects will be required to refrain from the use of any vitamin supplement for one week prior to initiation of the study and for the duration of the study. They may consume their normal diet during the study. On the days of the "Blood Collection" visits, the subjects arrive at the CRC having not eaten breakfast. Breakfast will be provided by the investigators prior to the insertion of the catheter. The subjects should drink plenty of water on the day before and the day of the study visit.
5 Saliva Collection Visit:
a. Subjects will report to the Food Science Building at a mutually-agreed upon time.
b. Subject will be instructed to brush their teeth with a new toothbrush and toothpaste (provided by investigator) prior to the start of the session.
c. Subjects will be instructed to consume 250 mL of tap water prior to starting the chewing gum treatment.
d. Prior to chewing, an unstimulated baseline saliva sample will be collected. e. Subjects will be randomly assigned to a treatment group and given the test gum (2 pieces of gum) and instructed to chew the gum for 30 min. To standardize chewing rate, subjects will be asked to chew in time to a metronome (set to 72 beats per minute) f. Subjects will then expectorate into a centrifuge tube at 2, 5, 15, and 30 min after chewing is commenced.
g. All saliva produced during the 30 min experiment will be collected, as well the gum.
6 Blood Collection Visits:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
15 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal